Pamela Vig, HEAD OF RESEARCH & DEVELOPMENT at Mirum Pharmaceuticals, Inc. (MIRM), sold 1,408 shares at $28.03 ($39K) on 2024-01-08, disclosed to the SEC on 2024-01-09.
Open-market sale of $39k MIRM by HEAD OF RESEARCH & DEVELOPMENT. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| MIRM | SELL | 2024-02-05 | $32K | — | Filing → |
| MIRM | SELL | 2023-07-05 | $37K | — | Filing → |
| MIRM | SELL | 2021-10-01 | $26K | — | Filing → |